Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders

Crescita Therapeutics announced the results from its Annual General and Special Meeting of Shareholders held on June 5, 2024, in Laval, Quebec.

Rhea-AI Impact

(Neutral)

Rhea-AI Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Tags

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

06/06/2024 - 07:30 AM EDT

LAVAL, Quebec--(BUSINESS WIRE)-- Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today announced the voting results from its Annual General and Special Meeting of Shareholders held at its corporate headquarters in Laval, Quebec on June 5, 2024. The detailed results of the votes received by proxy are as follows:

Election of Directors

Director Nominees	NUMBER OF SHARES		PERCENTAGE OF VOTES CAST
Director Nominees	FOR	WITHHELD	FOR	WITHHELD
Daniel N. Chicoine	6,490,732	109,026	98.3%	1.7%
Anthony E. Dobranowski	6,508,888	90,870	98.6%	1.4%
John C. London	6,533,190	66,568	99.0%	1.0%
Deborah Shannon-Trudeau	6,541,297	58,461	99.1%	0.9%
Serge Verreault	6,590,211	9,547	99.9%	0.1%

Reappointment of External Auditors

Outcome

NUMBER OF SHARES

PERCENTAGE OF VOTES CAST

FOR

WITHHELD

FOR

WITHHELD

Ernst & Young LLP reappointed

7,212,551

148,556

98.0%

2.0%

Approval of the Continuation of Crescita’s Share Incentive Plan

Outcome

NUMBER OF SHARES

PERCENTAGE OF VOTES CAST

FOR

AGAINST

FOR

AGAINST

Share Incentive Plan approved

6,526,477

73,281

98.9%

1.1%

About Crescita Therapeutics Inc.

Crescita (TSX: CTX and OTC US: CRRTF) is a growth-oriented, innovation-driven Canadian commercial dermatology company with in-house R&D and manufacturing capabilities. The Company offers a portfolio of high-quality, science-based non-prescription skincare products and a commercial stage prescription product. We also own multiple proprietary transdermal delivery platforms that support the development of patented formulations to facilitate the delivery of active ingredients into or through the skin. For more information visit, www.crescitatherapeutics.com.

Source: Crescita Therapeutics